Package 27241-159-19

Brand: valganciclovir hydrochloride

Generic: valganciclovir hydrochloride
NDC Package

Package Facts

Identity

Package NDC 27241-159-19
Digits Only 2724115919
Product NDC 27241-159
Product ID 27241-159_6f6211f4-3501-4957-92a1-bd68f2962203
Description

1 POUCH in 1 CARTON (27241-159-19) / 1 BOTTLE in 1 POUCH / 100 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2020-01-13
Brand valganciclovir hydrochloride
Generic valganciclovir hydrochloride
Sample Package No

Linked Drug Pages (1)

Valganciclovir hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "6f6211f4-3501-4957-92a1-bd68f2962203", "openfda": {"upc": ["0327241159190"], "unii": ["4P3T9QF9NZ"], "rxcui": ["863559"], "spl_set_id": ["178a014b-92c7-44a7-abb8-95d89a2feb8f"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (27241-159-19)  / 1 BOTTLE in 1 POUCH / 100 mL in 1 BOTTLE", "package_ndc": "27241-159-19", "marketing_start_date": "20200113"}], "brand_name": "Valganciclovir hydrochloride", "product_id": "27241-159_6f6211f4-3501-4957-92a1-bd68f2962203", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "DNA Polymerase Inhibitors [MoA]", "Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "27241-159", "generic_name": "Valganciclovir hydrochloride", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valganciclovir hydrochloride", "active_ingredients": [{"name": "VALGANCICLOVIR HYDROCHLORIDE", "strength": "50 mg/mL"}], "application_number": "ANDA212890", "marketing_category": "ANDA", "marketing_start_date": "20200113", "listing_expiration_date": "20271231"}